Abstract
Chronic refractory back pain has a major negative impact on mental health and quality of life (QOL), and a high societal cost in terms of lost productivity and health care utilization (HCU)1. Few treatment options exist for chronic back pain patients who have failed conventional medical management (CMM) and who have not had and are not candidates for back surgery2, a condition we refer to as non-surgical refractory back pain (NSRBP). The objective of this multicenter, randomized controlled trial (RCT) is to produce evidence comparing 10kHz-SCS plus CMM (10kHz-SCS+CMM) to CMM alone for treatment of NSRBP in terms of clinical- and cost-effectiveness.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
